NeuroSense Therapeutics Ltd. (NRSN)
USD 1.14
(5.56%)
USD 1.14
(5.56%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -8.27 Million | -7.58 Million | -1.53 Million | -695 Thousand | -582 Thousand |
| Net Income | -11.28 Million | -12.34 Million | -4.04 Million | -2.82 Million | -1.22 Million |
| Depreciation & Amortization | 97 Thousand | 89 Thousand | 3000.00 | 3000.00 | - |
| Deferred income taxes | -2.01 Million | - | -2.72 Million | 2000.00 | - |
| Stock-based compensation | 2.79 Million | 5.1 Million | 4.15 Million | 2.06 Million | 611 Thousand |
| Change in working capital | 1.9 Million | 750 Thousand | 273 Thousand | 69 Thousand | 29 Thousand |
| Other non-cash items | 215 Thousand | -1.19 Million | 791 Thousand | -2000.00 | 591 Thousand |
| Investing Cash Flow | 3.46 Million | -3.54 Million | -17 Thousand | -9000.00 | -26 Thousand |
| Investments in PPE | -29 Thousand | -70 Thousand | -17 Thousand | -9000.00 | -7000.00 |
| Acquisitions | 3000.00 | - | - | - | - |
| Investment purchases | -3000.00 | -3.5 Million | - | - | -19 Thousand |
| Sales/Maturities of investments | 3.5 Million | - | - | - | - |
| Other Investing Activities | -3000.00 | 29 Thousand | - | - | -19 Thousand |
| Financing Cash Flow | 3.89 Million | 3.69 Million | 11.9 Million | 508 Thousand | 1.41 Million |
| Debt repayment | -80 Thousand | -79 Thousand | -1.23 Million | - | -3000.00 |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 3.97 Million | 3.87 Million | 9.86 Million | 508 Thousand | 1.42 Million |
| Other Financing Activities | 3975.00 | -96 Thousand | 3.27 Million | 508.00 | -3000.00 |
| Accounts receivables | 19 Thousand | 55 Thousand | -204 Thousand | -12 Thousand | -3000.00 |
| Accounts payables | 961 Thousand | 459 Thousand | -16 Thousand | 32 Thousand | 23 Thousand |
| Inventory | - | -55 Thousand | 204 Thousand | 12 Thousand | 3000.00 |
| Other working capital | 928 Thousand | 291 Thousand | 289 Thousand | 37 Thousand | 6000.00 |
| Cash at beginning of period | 3.57 Million | 11.06 Million | 699 Thousand | 895 Thousand | 86 Thousand |
| Cash at end of period | 2.68 Million | 3.54 Million | 11.06 Million | 699 Thousand | 895 Thousand |
| Capital Expenditure | -29 Thousand | -70 Thousand | -17 Thousand | -9000.00 | -7000.00 |
| Effect of forex changes on cash | 8000.00 | -88 Thousand | 18 Thousand | - | - |
| Net cash flow / Change in cash | -899 Thousand | -7.52 Million | 10.36 Million | -196 Thousand | 809 Thousand |
| Free Cash Flow | -8.3 Million | -7.65 Million | -1.55 Million | -704 Thousand | -589 Thousand |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -5404.00 | -11.28 Million | -1777.00 | 784.00 | -5225.00 | -3889.00 |
| Depreciation & Amortization | - | 97 Thousand | - | - | - | - |
| Deferred income taxes | - | -2.01 Million | - | - | - | - |
| Stock-based compensation | - | 2.79 Million | 1537.00 | -1784.00 | 1784.00 | - |
| Change in working capital | - | 1.9 Million | - | - | - | - |
| Other non-cash items | 5404.00 | 215 Thousand | 240.00 | 1000.00 | 3441.00 | 3889.00 |
| Investing Cash Flow | - | 3.46 Million | - | - | - | - |
| Investments in PPE | - | -29 Thousand | - | - | - | - |
| Acquisitions | - | 3000.00 | - | - | - | - |
| Investment purchases | - | -3000.00 | - | - | - | - |
| Sales/Maturities of investments | - | 3.5 Million | - | - | - | - |
| Other Investing Activities | - | -3000.00 | - | - | - | - |
| Financing Cash Flow | - | 3.89 Million | - | - | - | - |
| Debt repayment | - | -80 Thousand | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 3.97 Million | - | - | - | - |
| Other Financing Activities | - | 3975.00 | - | - | - | - |
| Accounts receivables | - | 19 Thousand | - | - | - | - |
| Accounts payables | - | 961 Thousand | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | 928 Thousand | - | - | - | - |
| Cash at beginning of period | - | 3.57 Million | - | 7.12 Million | 1.39 Million | 3.57 Million |
| Cash at end of period | - | 2.68 Million | - | 4.79 Million | 7.12 Million | 1.39 Million |
| Capital Expenditure | - | -29 Thousand | - | - | - | - |
| Effect of forex changes on cash | - | 8000.00 | - | - | - | - |
| Net cash flow / Change in cash | - | -899 Thousand | - | -2.33 Million | 5.72 Million | -2.18 Million |
| Free Cash Flow | - | -8.3 Million | - | - | 1784.00 | - |
TTR1
TTA
SAAM
SKUYF
AAG
ALDLT